NWL
41
-3
QCOM
70
-3
SYF
92
-3
PHM
69
-2
AN
55
-3
MLM
67
-9
KMX
46
-2
CNX
61
-8
RRC
66
-10
PAYX
42
-9
VFC
15
-3
CF
26
-6
CAT
62
-4
EQT
57
-7
HIG
68
-2
EQR
62
-5
EXPE
58
-3
APD
39
-6
HST
38
-7
JPM
63
-3
NWL
41
-3
QCOM
70
-3
SYF
92
-3
PHM
69
-2
AN
55
-3
MLM
67
-9
KMX
46
-2
CNX
61
-8
RRC
66
-10
PAYX
42
-9
VFC
15
-3
CF
26
-6
CAT
62
-4
EQT
57
-7
HIG
68
-2
EQR
62
-5
EXPE
58
-3
APD
39
-6
HST
38
-7
JPM
63
-3
Financhill
Back

Royalty Pharma PLC Quote, Financials, Valuation and Earnings

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.
Sell
23

RPRX
Royalty Pharma PLC

Last Price:
28.07
Seasonality Move:
-7.4%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Royalty Pharma PLC Price Quote

$28.07

Royalty Pharma PLC Key Stats

Sell
23
Royalty Pharma PLC (RPRX) is a Sell
Day range:
$27.70 - $28.21
52-week range:
$25.92 - $35.76
Dividend yield:
2.89%
P/E ratio:
11.09
P/S ratio:
7.19
P/B ratio:
1.92%
Volume:
3.1M
Avg. volume:
2.5M
1-year change:
-20.55%
Market cap:
$12.5B
Revenue:
$2.4B
EPS:
$2.52

How Much Does Royalty Pharma PLC Make?

Is Royalty Pharma PLC Growing As A Company?

  • What Is Royalty Pharma PLC's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Royalty Pharma PLC's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Royalty Pharma PLC Stock Price Performance

What Is Royalty Pharma PLC 52-Week High & Low?

Royalty Pharma PLC Price To Free Cash Flow

Is It Risky To Buy Royalty Pharma PLC?

Is Royalty Pharma PLC Cash Flow Positive?

  • What Is RPRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $3B
  • What Is Royalty Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.1B
  • What Is Royalty Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.1B

Royalty Pharma PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    RPRX return on invested capital is 6.88%
  • What Is Royalty Pharma PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 6.82%
  • What Is RPRX Return On Equity?
    ROE is a measure of profitability and is 11.62%

Royalty Pharma PLC Earnings Date & Stock Price

Royalty Pharma PLC Competitors

  • Who Are Royalty Pharma PLC's Competitors?
    Below is a list of companies who compete with Royalty Pharma PLC or are related in some way:
    • Amphastar Pharmaceuticals Inc (AMPH)
    • Maravai LifeSciences Holdings Inc (MRVI)
    • Pacira BioSciences Inc (PCRX)
    • Viatris Inc (VTRS)
    • Walgreens Boots Alliance Inc (WBA)

Royalty Pharma PLC Dividend Yield

Royalty Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 51.7%
Revenue: 5.36% -11.64%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 45.40
Upside from Last Price: 61.74%

Major Shareholders

  • How many RPRX shares are owned by institutional investors?
    483.6M RPRX shares are owned by institutional investors
  • How many RPRX shares are owned by insiders?
    822.1K RPRX shares are owned by insiders